Congrats, Angel. That almost qualifies as DD. But a copy/pasted report on how world cancer rates are on the rise doesn't mean SBFM management "swindled" anybody. If anything, it's setting the stage for an even bigger following when Adva-27a begins trials. Interest will be even greater since dozens and dozens of new cancer drugs in development are not going to make to market.